Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY | - | Yearly | 89+0 | - | 9 |
| Course Program | Salı 09:00-09:45 Salı 10:00-10:45 Salı 11:00-11:45 Salı 12:00-12:45 Salı 12:45-13:30 Salı 13:30-14:15 Salı 16:30-17:15 Salı 17:30-18:15 Salı 18:30-19:15 Salı 20:30-21:15 Salı 21:30-22:15 Salı 22:30-23:15 Salı 23:30-00:15 Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 Çarşamba 11:00-11:45 Çarşamba 12:45-13:30 Çarşamba 13:30-14:15 Çarşamba 17:30-18:15 Çarşamba 18:30-19:15 Çarşamba 19:30-20:15 Perşembe 09:00-09:45 Perşembe 10:00-10:45 Perşembe 16:30-17:15 Perşembe 17:30-18:15 Perşembe 18:30-19:15 Cuma 16:30-17:15 Cuma 17:30-18:15 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee Course |
| Course Coordinator | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Name of Lecturer(s) | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Assistant(s) | |
| Aim | The aim of this course is to teach the general pharmacology subjects and the pharmacological properties of drugs that affect body systems. |
| Course Content | This course contains; Drugs Used in the Treatment of Anemia,Antiviral drugs,Immunomodulator Drugs,Pharmacological Principles of Cancer Treatment,Antineoplastic Drugs,Toxic Effects of Drugs and Basic Concepts of Toxicology,Antihypertensive Drugs,Pharmacological Aspects of Autonomic Nervous System,Anticoagulant Drugs,Antiplatelet and Fibrinolytic Drugs,Beta-Adrenergic Receptor Blockers,Drugs Used in the Treatment of Angina Pectoris,Parasympathomimetic and Anticholinesterase Drugs,Parasympatholytic Drugs,Sympathomimetic Drugs,Sympatholytic drugs,Nicotine, Ganglion Stimulants, Ganglion Blockers,Drugs Used in Water and Electrolyte Balance Disorders,Acid-Base Balance Disorders,Peripheral Vasodilators,Drugs Used in Heart Failure: Heart Glycosides,Other Drugs Used in Heart Failure,Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume,Hypolipidemic Drugs,Drugs Used in Cardiac Dermatitis,Antihistaminic Drugs,Cough Treatment and Drugs Used in Colds,Bronchodilator Drugs,Antitussive Drugs, Expectorants and Mucolytics,Vitamins,Oxygen, Ozone and Other Treatment Gases,Thyroid Hormones and Antithyroid Drugs,Drugs Affecting Bone Mineral Homeostasis,Insulin, Oral Antidiabetic Drugs and Glucagon,Corticosteroids, Antagonists and ACTH,Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides,Anti-Malarial Drugs,Antihelmintik Drugs,Ectoparasitic Drugs,Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs,Traditional and Complementary Medicine Applications,Digestive Auxiliary Drugs and Antidiarrheals,Drugs Used in Peptic Ulcer Treatment,Laxatives and Purgatives,Pharmacovigilance,Emetic, Antiemetic and Prokinetic Drugs,Androgens, Anabolic Steroids and Antiandrogenic Drugs,Female Gender Hormones,Oxytocic Drugs,Contraceptive drugs,Diuretics,Drugs Specific to the Treatment of Urinary Infections,Drug Innovation - Introduction to Clinical Pharmacology,Principles of Rational Drug Use,Fundamentals of Central Nervous System Pharmacology,Drugs Used in Dementia Treatment,Neuroleptic Drugs (Antipsychotic Drugs),Antidepressant and Antimanic Drugs,Pharmacology of General Anesthesia and General Anesthetics,Central Nervous System Situmulants and Hallucinogens,Narcotic (Opioid) Analgesics,Antiepileptic Drugs,Drug Abuse and Addiction,Hypnotics,Alcohols,Drugs Used in Headache,Drugs Used in Dementia Treatment,Antiparkinson Drugs,Non-Steroidal Anti-Inflammatory Drugs,Acetaminophen,Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers,Local Anesthetic Drugs,Prescription Information,Drugs Used in Gout Treatment,Clinical Toxicology. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| Evaluate the main subjects of pharmacology. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the drug toxicity and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| Gains knowledge about the central nervous stystem (CNS) drugs and mechanism. | 10, 13, 16, 19, 4, 9 | A |
| Evaluate the analgesics, anti-inflammatories and anesthetics. | 10, 13, 16, 19, 4, 9 | A |
| Explains pharmacokinetics and pharmacodynamics of autonomous drugs. They can also discuss their adverse effect profiles and drug interactions. | 10, 13, 16, 19, 4, 9 | A |
| Explains the pharmacokinetics and pharmacodynamics of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. They also discuss side effect profiles and interactions of these drugs. | 10, 13, 16, 19, 4, 9 | A |
| Summarizes the pharmacokinetic, pharmacodynamics, adverse effects, contraindications and drug interactions of the endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. | 10, 13, 16, 19, 3, 4, 9 | A |
| Interprets the mechanisms of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. | 10, 13, 16, 19, 4 | A |
| Summarizes the pharmacokinetics, pharmacodynamics, adverse effects, contraindications and drug interactions of the autonom drugs. | 10, 13, 16, 19, 4, 9 | A |
| Interpret the mechanisms of autonomous drugs. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of autonomic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs | 10, 13, 16, 19, 4, 9 | A |
| Interprets the mechanisms of analgesic, anti-inflammatory and anesthetic drugs action. | 10, 13, 16, 19, 4, 9 | A |
| Gives examples of analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identify the pharmacokinetics and pharmacodynamics of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Explains the functions such as pharmacokinetics and pharmacodynamics of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Gives examples of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Explains the drug toxicity and their mechanism. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of drug toxicity, and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the functions of the drug pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| Explains the pharmacokinetic and pharmacodynamic functions of drugs. | 10, 13, 16, 19, 4, 9 | A |
| Summarize the drugs pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Drugs Used in the Treatment of Anemia | Preparation for the previously given lecture note |
| 2 | Antiviral drugs | Preparation for the previously given lecture note |
| 3 | Immunomodulator Drugs | Preparation for the previously given lecture note |
| 4 | Pharmacological Principles of Cancer Treatment | Preparation for the previously given lecture note |
| 5 | Antineoplastic Drugs | Preparation for the previously given lecture note |
| 6 | Toxic Effects of Drugs and Basic Concepts of Toxicology | Preparation for the previously given lecture note |
| 7 | Antihypertensive Drugs | Preparation for the previously given lecture note |
| 8 | Pharmacological Aspects of Autonomic Nervous System | Preparation for the previously given lecture note |
| 9 | Anticoagulant Drugs | Preparation for the previously given lecture note |
| 10 | Antiplatelet and Fibrinolytic Drugs | Preparation for the previously given lecture note |
| 11 | Beta-Adrenergic Receptor Blockers | Preparation for the previously given lecture note |
| 12 | Drugs Used in the Treatment of Angina Pectoris | Preparation for the previously given lecture note |
| 13 | Parasympathomimetic and Anticholinesterase Drugs | Preparation for the previously given lecture note |
| 14 | Parasympatholytic Drugs | Preparation for the previously given lecture note |
| 15 | Sympathomimetic Drugs | Preparation for the previously given lecture note |
| 16 | Sympatholytic drugs | Preparation for the previously given lecture note |
| 17 | Nicotine, Ganglion Stimulants, Ganglion Blockers | Preparation for the previously given lecture note |
| 18 | Drugs Used in Water and Electrolyte Balance Disorders | Preparation for the previously given lecture note |
| 19 | Acid-Base Balance Disorders | Preparation for the previously given lecture note |
| 20 | Peripheral Vasodilators | Preparation for the previously given lecture note |
| 21 | Drugs Used in Heart Failure: Heart Glycosides | Preparation for the previously given lecture note |
| 22 | Other Drugs Used in Heart Failure | Preparation for the previously given lecture note |
| 23 | Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume | Preparation for the previously given lecture note |
| 24 | Hypolipidemic Drugs | Preparation for the previously given lecture note |
| 25 | Drugs Used in Cardiac Dermatitis | Preparation for the previously given lecture note |
| 26 | Antihistaminic Drugs | Preparation for the previously given lecture note |
| 27 | Cough Treatment and Drugs Used in Colds | Preparation for the previously given lecture note |
| 28 | Bronchodilator Drugs | Preparation for the previously given lecture note |
| 29 | Antitussive Drugs, Expectorants and Mucolytics | Preparation for the previously given lecture note |
| 30 | Vitamins | Preparation for the previously given lecture note |
| 31 | Oxygen, Ozone and Other Treatment Gases | Preparation for the previously given lecture note |
| 60 | Thyroid Hormones and Antithyroid Drugs | Preparation for the previously given lecture note |
| 61 | Drugs Affecting Bone Mineral Homeostasis | Preparation for the previously given lecture note |
| 62 | Insulin, Oral Antidiabetic Drugs and Glucagon | Preparation for the previously given lecture note |
| 63 | Corticosteroids, Antagonists and ACTH | Preparation for the previously given lecture note |
| 64 | Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides | Preparation for the previously given lecture note |
| 65 | Anti-Malarial Drugs | Preparation for the previously given lecture note |
| 66 | Antihelmintik Drugs | Preparation for the previously given lecture note |
| 67 | Ectoparasitic Drugs | Preparation for the previously given lecture note |
| 68 | Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs | Preparation for the previously given lecture note |
| 69 | Traditional and Complementary Medicine Applications | Preparation for the previously given lecture note |
| 70 | Digestive Auxiliary Drugs and Antidiarrheals | Preparation for the previously given lecture note |
| 71 | Drugs Used in Peptic Ulcer Treatment | Preparation for the previously given lecture note |
| 72 | Laxatives and Purgatives | Preparation for the previously given lecture note |
| 73 | Pharmacovigilance | Preparation for the previously given lecture note |
| 74 | Emetic, Antiemetic and Prokinetic Drugs | Preparation for the previously given lecture note |
| 75 | Androgens, Anabolic Steroids and Antiandrogenic Drugs | Preparation for the previously given lecture note |
| 76 | Female Gender Hormones | Preparation for the previously given lecture note |
| 77 | Oxytocic Drugs | Preparation for the previously given lecture note |
| 78 | Contraceptive drugs | Preparation for the previously given lecture note |
| 79 | Diuretics | Preparation for the previously given lecture note |
| 80 | Drugs Specific to the Treatment of Urinary Infections | Preparation for the previously given lecture note |
| 81 | Drug Innovation - Introduction to Clinical Pharmacology | Preparation for the previously given lecture note |
| 82 | Principles of Rational Drug Use | Preparation for the previously given lecture note |
| 83 | Fundamentals of Central Nervous System Pharmacology | Preparation for the previously given lecture note |
| 84 | Drugs Used in Dementia Treatment | Preparation for the previously given lecture note |
| 85 | Neuroleptic Drugs (Antipsychotic Drugs) | Preparation for the previously given lecture note |
| 86 | Antidepressant and Antimanic Drugs | Preparation for the previously given lecture note |
| 87 | Pharmacology of General Anesthesia and General Anesthetics | Preparation for the previously given lecture note |
| 88 | Central Nervous System Situmulants and Hallucinogens | Preparation for the previously given lecture note |
| 89 | Narcotic (Opioid) Analgesics | Preparation for the previously given lecture note |
| 90 | Antiepileptic Drugs | Preparation for the previously given lecture note |
| 91 | Drug Abuse and Addiction | Preparation for the previously given lecture note |
| 92 | Hypnotics | Preparation for the previously given lecture note |
| 93 | Alcohols | Preparation for the previously given lecture note |
| 94 | Drugs Used in Headache | Preparation for the previously given lecture note |
| 95 | Drugs Used in Dementia Treatment | Preparation for the previously given lecture note |
| 96 | Antiparkinson Drugs | Preparation for the previously given lecture note |
| 97 | Non-Steroidal Anti-Inflammatory Drugs | Preparation for the previously given lecture note |
| 98 | Acetaminophen | Preparation for the previously given lecture note |
| 99 | Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers | Preparation for the previously given lecture note |
| 100 | Local Anesthetic Drugs | Preparation for the previously given lecture note |
| 101 | Prescription Information | Preparation for the previously given lecture note |
| 102 | Drugs Used in Gout Treatment | Preparation for the previously given lecture note |
| 103 | Clinical Toxicology | Preparation for the previously given lecture note |
| Resources |
| Pharmacology notes given to the students. |
| Goodman & Gilman's Pharmacological Basis of Treatment - / Laurence L.Brunton - John S.Lazo - Keith L.Parker Nobel Medical Bookstores Publications, Istanbul, 2008 Katzung & Trevor's Pharmacology Examination and Board Review: Eighth Edition McGraw-Hill Medical Publishing USA, 2008. Medical Pharmacology in the Direction of Rational Treatment 13th Edition - Prof.Dr. Oğuz Kayaalp, Pelikan Publications, 2012. Pharmacology for Health Sciences - Asist. Prof. A. Arzu SAYIN ŞAKUL, Istanbul Medical Publications, 2021 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | Knows structural (morphological) and operational (functional) properties of the normal human (medical) and disorder (disease) states | X | |||||
| 2 | Knows diagnostic methods and treatment modalities of disorders (diseases). | X | |||||
| 3 | Knows the causes of disease conditions, ways of protection and methods of promoting and improving community health. | X | |||||
| 4 | Knows the methods of developing and applying health related knowledge at advanced level. | X | |||||
| 5 | Able to reach multidisciplinary advanced knowledge regarding health-related disciplines, interpret and apply the knowledge. | X | |||||
| 6 | Performs a complete clinical examination of human body structurally and functionally and identifies problems. | X | |||||
| 7 | Interprets laboratory results for diagnosis, compares with clinical data and develop solution proposals. | X | |||||
| 8 | Selects and implements appropriate tools for the promotion and development of individual and community health. | X | |||||
| 9 | Plans and conducts an advanced study on health independently. | X | |||||
| 10 | Develops new strategic approaches to solve the problems encountered in the promotion and development of individual and community health. | X | |||||
| 11 | Takes the responsibility of any type of practice when diagnosing and treating human body | X | |||||
| 12 | Takes the role as a leader or a team worker when solving health related problems. | X | |||||
| 13 | Evaluates knowledge and skills regarding health with a critical approach and develops a positive attitude towards lifelong learning. | X | |||||
| 14 | Informs the patient, related people, institutions and the society about the health problems and transfers solution proposals in writing, verbally and visually using effective communication means. | X | |||||
| 15 | Critically reviews, develops and acts on changes in social relations and norms that guide such relationships. | X | |||||
| 16 | Uses English at least at the European Language Portfolio B2 Level, monitors knowledge and communicates in his field. | X | |||||
| 17 | Able to use advanced computer skills and informatics and communication technologies at a level required by the field. | X | |||||
| 18 | Acquires, interprets, implements and announces data related to the health and acts in accordance with social, scientific, cultural and ethical values and teaches these values. | X | |||||
| 19 | Develops strategies, policy and implementation plans in the field of health and evaluates the results obtained within the framework of quality processes. | X | |||||
| 20 | Shares studies on the promotion and development of health with interdisciplinary specialists systematically, supporting with quantitative and qualitative data. | X | |||||
| 21 | Has adequate awareness on occupational health and safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 28 | 4 | 112 | |||
| Guided Problem Solving | 10 | 1 | 10 | |||
| Resolution of Homework Problems and Submission as a Report | 7 | 2 | 14 | |||
| Term Project | 5 | 3 | 15 | |||
| Presentation of Project / Seminar | 14 | 1 | 14 | |||
| Quiz | 4 | 1 | 4 | |||
| Midterm Exam | 14 | 3 | 42 | |||
| General Exam | 14 | 4 | 56 | |||
| Performance Task, Maintenance Plan | 4 | 3 | 12 | |||
| Total Workload(Hour) | 279 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(279/30) | 9 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY | - | Yearly | 89+0 | - | 9 |
| Course Program | Salı 09:00-09:45 Salı 10:00-10:45 Salı 11:00-11:45 Salı 12:00-12:45 Salı 12:45-13:30 Salı 13:30-14:15 Salı 16:30-17:15 Salı 17:30-18:15 Salı 18:30-19:15 Salı 20:30-21:15 Salı 21:30-22:15 Salı 22:30-23:15 Salı 23:30-00:15 Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 Çarşamba 11:00-11:45 Çarşamba 12:45-13:30 Çarşamba 13:30-14:15 Çarşamba 17:30-18:15 Çarşamba 18:30-19:15 Çarşamba 19:30-20:15 Perşembe 09:00-09:45 Perşembe 10:00-10:45 Perşembe 16:30-17:15 Perşembe 17:30-18:15 Perşembe 18:30-19:15 Cuma 16:30-17:15 Cuma 17:30-18:15 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee Course |
| Course Coordinator | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Name of Lecturer(s) | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Assistant(s) | |
| Aim | The aim of this course is to teach the general pharmacology subjects and the pharmacological properties of drugs that affect body systems. |
| Course Content | This course contains; Drugs Used in the Treatment of Anemia,Antiviral drugs,Immunomodulator Drugs,Pharmacological Principles of Cancer Treatment,Antineoplastic Drugs,Toxic Effects of Drugs and Basic Concepts of Toxicology,Antihypertensive Drugs,Pharmacological Aspects of Autonomic Nervous System,Anticoagulant Drugs,Antiplatelet and Fibrinolytic Drugs,Beta-Adrenergic Receptor Blockers,Drugs Used in the Treatment of Angina Pectoris,Parasympathomimetic and Anticholinesterase Drugs,Parasympatholytic Drugs,Sympathomimetic Drugs,Sympatholytic drugs,Nicotine, Ganglion Stimulants, Ganglion Blockers,Drugs Used in Water and Electrolyte Balance Disorders,Acid-Base Balance Disorders,Peripheral Vasodilators,Drugs Used in Heart Failure: Heart Glycosides,Other Drugs Used in Heart Failure,Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume,Hypolipidemic Drugs,Drugs Used in Cardiac Dermatitis,Antihistaminic Drugs,Cough Treatment and Drugs Used in Colds,Bronchodilator Drugs,Antitussive Drugs, Expectorants and Mucolytics,Vitamins,Oxygen, Ozone and Other Treatment Gases,Thyroid Hormones and Antithyroid Drugs,Drugs Affecting Bone Mineral Homeostasis,Insulin, Oral Antidiabetic Drugs and Glucagon,Corticosteroids, Antagonists and ACTH,Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides,Anti-Malarial Drugs,Antihelmintik Drugs,Ectoparasitic Drugs,Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs,Traditional and Complementary Medicine Applications,Digestive Auxiliary Drugs and Antidiarrheals,Drugs Used in Peptic Ulcer Treatment,Laxatives and Purgatives,Pharmacovigilance,Emetic, Antiemetic and Prokinetic Drugs,Androgens, Anabolic Steroids and Antiandrogenic Drugs,Female Gender Hormones,Oxytocic Drugs,Contraceptive drugs,Diuretics,Drugs Specific to the Treatment of Urinary Infections,Drug Innovation - Introduction to Clinical Pharmacology,Principles of Rational Drug Use,Fundamentals of Central Nervous System Pharmacology,Drugs Used in Dementia Treatment,Neuroleptic Drugs (Antipsychotic Drugs),Antidepressant and Antimanic Drugs,Pharmacology of General Anesthesia and General Anesthetics,Central Nervous System Situmulants and Hallucinogens,Narcotic (Opioid) Analgesics,Antiepileptic Drugs,Drug Abuse and Addiction,Hypnotics,Alcohols,Drugs Used in Headache,Drugs Used in Dementia Treatment,Antiparkinson Drugs,Non-Steroidal Anti-Inflammatory Drugs,Acetaminophen,Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers,Local Anesthetic Drugs,Prescription Information,Drugs Used in Gout Treatment,Clinical Toxicology. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| Evaluate the main subjects of pharmacology. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the drug toxicity and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| Gains knowledge about the central nervous stystem (CNS) drugs and mechanism. | 10, 13, 16, 19, 4, 9 | A |
| Evaluate the analgesics, anti-inflammatories and anesthetics. | 10, 13, 16, 19, 4, 9 | A |
| Explains pharmacokinetics and pharmacodynamics of autonomous drugs. They can also discuss their adverse effect profiles and drug interactions. | 10, 13, 16, 19, 4, 9 | A |
| Explains the pharmacokinetics and pharmacodynamics of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. They also discuss side effect profiles and interactions of these drugs. | 10, 13, 16, 19, 4, 9 | A |
| Summarizes the pharmacokinetic, pharmacodynamics, adverse effects, contraindications and drug interactions of the endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. | 10, 13, 16, 19, 3, 4, 9 | A |
| Interprets the mechanisms of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of endocrine, cardiovascular, respiratory and gastrointestinal system drugs. | 10, 13, 16, 19, 4 | A |
| Summarizes the pharmacokinetics, pharmacodynamics, adverse effects, contraindications and drug interactions of the autonom drugs. | 10, 13, 16, 19, 4, 9 | A |
| Interpret the mechanisms of autonomous drugs. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of autonomic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs | 10, 13, 16, 19, 4, 9 | A |
| Interprets the mechanisms of analgesic, anti-inflammatory and anesthetic drugs action. | 10, 13, 16, 19, 4, 9 | A |
| Gives examples of analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| Identify the pharmacokinetics and pharmacodynamics of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Explains the functions such as pharmacokinetics and pharmacodynamics of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Gives examples of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| Explains the drug toxicity and their mechanism. | 10, 13, 16, 19, 4, 9 | A |
| Give examples of drug toxicity, and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| Identifies the functions of the drug pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| Explains the pharmacokinetic and pharmacodynamic functions of drugs. | 10, 13, 16, 19, 4, 9 | A |
| Summarize the drugs pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Drugs Used in the Treatment of Anemia | Preparation for the previously given lecture note |
| 2 | Antiviral drugs | Preparation for the previously given lecture note |
| 3 | Immunomodulator Drugs | Preparation for the previously given lecture note |
| 4 | Pharmacological Principles of Cancer Treatment | Preparation for the previously given lecture note |
| 5 | Antineoplastic Drugs | Preparation for the previously given lecture note |
| 6 | Toxic Effects of Drugs and Basic Concepts of Toxicology | Preparation for the previously given lecture note |
| 7 | Antihypertensive Drugs | Preparation for the previously given lecture note |
| 8 | Pharmacological Aspects of Autonomic Nervous System | Preparation for the previously given lecture note |
| 9 | Anticoagulant Drugs | Preparation for the previously given lecture note |
| 10 | Antiplatelet and Fibrinolytic Drugs | Preparation for the previously given lecture note |
| 11 | Beta-Adrenergic Receptor Blockers | Preparation for the previously given lecture note |
| 12 | Drugs Used in the Treatment of Angina Pectoris | Preparation for the previously given lecture note |
| 13 | Parasympathomimetic and Anticholinesterase Drugs | Preparation for the previously given lecture note |
| 14 | Parasympatholytic Drugs | Preparation for the previously given lecture note |
| 15 | Sympathomimetic Drugs | Preparation for the previously given lecture note |
| 16 | Sympatholytic drugs | Preparation for the previously given lecture note |
| 17 | Nicotine, Ganglion Stimulants, Ganglion Blockers | Preparation for the previously given lecture note |
| 18 | Drugs Used in Water and Electrolyte Balance Disorders | Preparation for the previously given lecture note |
| 19 | Acid-Base Balance Disorders | Preparation for the previously given lecture note |
| 20 | Peripheral Vasodilators | Preparation for the previously given lecture note |
| 21 | Drugs Used in Heart Failure: Heart Glycosides | Preparation for the previously given lecture note |
| 22 | Other Drugs Used in Heart Failure | Preparation for the previously given lecture note |
| 23 | Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume | Preparation for the previously given lecture note |
| 24 | Hypolipidemic Drugs | Preparation for the previously given lecture note |
| 25 | Drugs Used in Cardiac Dermatitis | Preparation for the previously given lecture note |
| 26 | Antihistaminic Drugs | Preparation for the previously given lecture note |
| 27 | Cough Treatment and Drugs Used in Colds | Preparation for the previously given lecture note |
| 28 | Bronchodilator Drugs | Preparation for the previously given lecture note |
| 29 | Antitussive Drugs, Expectorants and Mucolytics | Preparation for the previously given lecture note |
| 30 | Vitamins | Preparation for the previously given lecture note |
| 31 | Oxygen, Ozone and Other Treatment Gases | Preparation for the previously given lecture note |
| 60 | Thyroid Hormones and Antithyroid Drugs | Preparation for the previously given lecture note |
| 61 | Drugs Affecting Bone Mineral Homeostasis | Preparation for the previously given lecture note |
| 62 | Insulin, Oral Antidiabetic Drugs and Glucagon | Preparation for the previously given lecture note |
| 63 | Corticosteroids, Antagonists and ACTH | Preparation for the previously given lecture note |
| 64 | Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides | Preparation for the previously given lecture note |
| 65 | Anti-Malarial Drugs | Preparation for the previously given lecture note |
| 66 | Antihelmintik Drugs | Preparation for the previously given lecture note |
| 67 | Ectoparasitic Drugs | Preparation for the previously given lecture note |
| 68 | Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs | Preparation for the previously given lecture note |
| 69 | Traditional and Complementary Medicine Applications | Preparation for the previously given lecture note |
| 70 | Digestive Auxiliary Drugs and Antidiarrheals | Preparation for the previously given lecture note |
| 71 | Drugs Used in Peptic Ulcer Treatment | Preparation for the previously given lecture note |
| 72 | Laxatives and Purgatives | Preparation for the previously given lecture note |
| 73 | Pharmacovigilance | Preparation for the previously given lecture note |
| 74 | Emetic, Antiemetic and Prokinetic Drugs | Preparation for the previously given lecture note |
| 75 | Androgens, Anabolic Steroids and Antiandrogenic Drugs | Preparation for the previously given lecture note |
| 76 | Female Gender Hormones | Preparation for the previously given lecture note |
| 77 | Oxytocic Drugs | Preparation for the previously given lecture note |
| 78 | Contraceptive drugs | Preparation for the previously given lecture note |
| 79 | Diuretics | Preparation for the previously given lecture note |
| 80 | Drugs Specific to the Treatment of Urinary Infections | Preparation for the previously given lecture note |
| 81 | Drug Innovation - Introduction to Clinical Pharmacology | Preparation for the previously given lecture note |
| 82 | Principles of Rational Drug Use | Preparation for the previously given lecture note |
| 83 | Fundamentals of Central Nervous System Pharmacology | Preparation for the previously given lecture note |
| 84 | Drugs Used in Dementia Treatment | Preparation for the previously given lecture note |
| 85 | Neuroleptic Drugs (Antipsychotic Drugs) | Preparation for the previously given lecture note |
| 86 | Antidepressant and Antimanic Drugs | Preparation for the previously given lecture note |
| 87 | Pharmacology of General Anesthesia and General Anesthetics | Preparation for the previously given lecture note |
| 88 | Central Nervous System Situmulants and Hallucinogens | Preparation for the previously given lecture note |
| 89 | Narcotic (Opioid) Analgesics | Preparation for the previously given lecture note |
| 90 | Antiepileptic Drugs | Preparation for the previously given lecture note |
| 91 | Drug Abuse and Addiction | Preparation for the previously given lecture note |
| 92 | Hypnotics | Preparation for the previously given lecture note |
| 93 | Alcohols | Preparation for the previously given lecture note |
| 94 | Drugs Used in Headache | Preparation for the previously given lecture note |
| 95 | Drugs Used in Dementia Treatment | Preparation for the previously given lecture note |
| 96 | Antiparkinson Drugs | Preparation for the previously given lecture note |
| 97 | Non-Steroidal Anti-Inflammatory Drugs | Preparation for the previously given lecture note |
| 98 | Acetaminophen | Preparation for the previously given lecture note |
| 99 | Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers | Preparation for the previously given lecture note |
| 100 | Local Anesthetic Drugs | Preparation for the previously given lecture note |
| 101 | Prescription Information | Preparation for the previously given lecture note |
| 102 | Drugs Used in Gout Treatment | Preparation for the previously given lecture note |
| 103 | Clinical Toxicology | Preparation for the previously given lecture note |
| Resources |
| Pharmacology notes given to the students. |
| Goodman & Gilman's Pharmacological Basis of Treatment - / Laurence L.Brunton - John S.Lazo - Keith L.Parker Nobel Medical Bookstores Publications, Istanbul, 2008 Katzung & Trevor's Pharmacology Examination and Board Review: Eighth Edition McGraw-Hill Medical Publishing USA, 2008. Medical Pharmacology in the Direction of Rational Treatment 13th Edition - Prof.Dr. Oğuz Kayaalp, Pelikan Publications, 2012. Pharmacology for Health Sciences - Asist. Prof. A. Arzu SAYIN ŞAKUL, Istanbul Medical Publications, 2021 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | Knows structural (morphological) and operational (functional) properties of the normal human (medical) and disorder (disease) states | X | |||||
| 2 | Knows diagnostic methods and treatment modalities of disorders (diseases). | X | |||||
| 3 | Knows the causes of disease conditions, ways of protection and methods of promoting and improving community health. | X | |||||
| 4 | Knows the methods of developing and applying health related knowledge at advanced level. | X | |||||
| 5 | Able to reach multidisciplinary advanced knowledge regarding health-related disciplines, interpret and apply the knowledge. | X | |||||
| 6 | Performs a complete clinical examination of human body structurally and functionally and identifies problems. | X | |||||
| 7 | Interprets laboratory results for diagnosis, compares with clinical data and develop solution proposals. | X | |||||
| 8 | Selects and implements appropriate tools for the promotion and development of individual and community health. | X | |||||
| 9 | Plans and conducts an advanced study on health independently. | X | |||||
| 10 | Develops new strategic approaches to solve the problems encountered in the promotion and development of individual and community health. | X | |||||
| 11 | Takes the responsibility of any type of practice when diagnosing and treating human body | X | |||||
| 12 | Takes the role as a leader or a team worker when solving health related problems. | X | |||||
| 13 | Evaluates knowledge and skills regarding health with a critical approach and develops a positive attitude towards lifelong learning. | X | |||||
| 14 | Informs the patient, related people, institutions and the society about the health problems and transfers solution proposals in writing, verbally and visually using effective communication means. | X | |||||
| 15 | Critically reviews, develops and acts on changes in social relations and norms that guide such relationships. | X | |||||
| 16 | Uses English at least at the European Language Portfolio B2 Level, monitors knowledge and communicates in his field. | X | |||||
| 17 | Able to use advanced computer skills and informatics and communication technologies at a level required by the field. | X | |||||
| 18 | Acquires, interprets, implements and announces data related to the health and acts in accordance with social, scientific, cultural and ethical values and teaches these values. | X | |||||
| 19 | Develops strategies, policy and implementation plans in the field of health and evaluates the results obtained within the framework of quality processes. | X | |||||
| 20 | Shares studies on the promotion and development of health with interdisciplinary specialists systematically, supporting with quantitative and qualitative data. | X | |||||
| 21 | Has adequate awareness on occupational health and safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |